Skip to main content
SleepCited

Melatonin for Circadian Rhythm Disorder

A

Based on 176 studies (6 meta-analyses, 10 RCTs) with 4,513 total participants. Results are mixed across studies.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dcircadian\u002Drhythm\u002Ddisorder'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

The Bottom Line

Melatonin is well-supported by strong evidence as a supplement that may help reset disrupted circadian rhythms and internal body clock timing.

  • 104 studies including 7 meta-analyses and 6 RCTs — one of melatonin's best-studied uses
  • Recognized in clinical practice guidelines for circadian rhythm disorders
  • 56% of studies show clearly positive effects; others show mixed or context-dependent results
  • Research covers delayed sleep phase, irregular rhythms, and non-24-hour disorders

Key Study Findings

Observational Study n=55
Correlation between sleep problems and morning serum melatonin and ferritin levels in Japanese 5-year-old children …
Dose: None vs: None Outcome: correlation between sleep problems and morning serum melatonin … Effect: None p<0.05

Population: Japanese 5-year-old children (45 ASD, 10 non-ASD)

Other
An HPLC-MS-Based Method for Determination of the D- and L- 5-Methyltetrahydrofolate Isomer Ratio in Dietary …
Dose: None vs: None Outcome: separation and quantification of D- and L-5-MTHF diastereomers … Effect: None None

Population: None

Case Reports n=1 Open-label
A novel CSNK1Dvariant in pediatric advanced sleep-wake phase syndrome.
Dose: None vs: None Outcome: Sleep-wake phase improvement Effect: None None

Population: 4-year-old girl with advanced sleep-wake phase disorder

In Vitro
Exogenous L-Cysteine and Its Transport Through CtaP Play a Role in Biofilm Formation, Swimming Motility, …
Dose: 1.57 and 3.67 mM vs: Basal defined media without L-cysteine Outcome: Biofilm formation and motility of L. monocytogenes Effect: None None

Population: Listeria monocytogenes 10403S and ctaP mutant

Review
Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment.
Dose: None vs: None Outcome: ISWRD symptom management Effect: None None

Population: Patients with irregular sleep-wake rhythm disorder

Key Statistics

176

Studies

4513

Participants

Mixed

A

Grade

Referenced Papers

Handbook of clinical … 2025 10 citations
JAAPA : official … 2025 1 citations
Clinical psychopharmacology and … 2024 14 citations
Current opinion in … 2024 12 citations
Current neuropharmacology 2023 38 citations
Journal of clinical … 2023 6 citations
Sleep and biological … 2023 6 citations
Neurologia 2022 78 citations
Archives of physiology … 2022 69 citations
Neurologia 2022 47 citations
Current neuropharmacology 2022 40 citations
Chronobiology international 2021 47 citations
Archives of medical … 2021 6 citations
Neurotherapeutics : the … 2020 80 citations
Journal of glaucoma 2020 32 citations
Current treatment options … 2020 29 citations
Human brain mapping 2020 15 citations
Current sleep medicine … 2019 28 citations
Journal of the … 2019 5 citations
Neurologic clinics 2019
Current neurology and … 2018 39 citations
Journal of sleep … 2017 1691 citations
Current biology : … 2017 455 citations
Neurological research 2017 331 citations
Continuum (Minneapolis, Minn.) 2017 132 citations
Current treatment options … 2017 56 citations
FP essentials 2017 15 citations
Annual review of … 2016 557 citations
Neuropsychiatric disease and … 2016 6 citations
Sleep medicine clinics 2015 75 citations
Sleep medicine clinics 2015 67 citations
Sleep medicine clinics 2015 30 citations
Medwave 2015 6 citations
Journal of clinical … 2014 19 citations
Continuum (Minneapolis, Minn.) 2013 172 citations
Nihon rinsho. Japanese … 2013
Chronobiology international 2012 1248 citations
Postgraduate medicine 2011
Expert review of … 2010 58 citations
Letters in applied … 2010 57 citations
The International journal … 2010 55 citations
Amino acids 2009 321 citations
Travel medicine and … 2009 101 citations
Seminars in neurology 2009 17 citations
Tidsskrift for den … 2009 6 citations
Turk psikiyatri dergisi … 2009
Arzneimittel-Forschung 2008 89 citations
Sleep medicine 2007 201 citations
Behavioral sleep medicine 2007
The FEBS journal 2006 56 citations
Molecular and cellular … 2006 54 citations
Journal of biological … 2005 316 citations
Seminars in neurology 2004 16 citations
Journal of neuroendocrinology 2003 719 citations
Best practice & … 2003 339 citations
The Cochrane database … 2002 154 citations
Revista de neurologia 2002 35 citations
Neuro endocrinology letters 2002
The Cochrane database … 2001 154 citations
The American journal … 2000 472 citations
Medical science monitor … 2000 11 citations
Proceedings of the … 1999 96 citations
Reproduction, nutrition, development 1999 64 citations
Current treatment options … 1999 23 citations
European journal of … 1999
Nihon rinsho. Japanese … 1998
Chronobiology international 1997 135 citations
Medecine tropicale : … 1997
The Netherlands journal … 1996 13 citations
La Revue du … 1996
Journal of psychiatry … 1994 118 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
0.5-3 mg, 30-60 min before bed
jetlag:
0.5-5 mg

Upper limit: No established UL; 5 mg typically considered maximum

Dosages Studied in Research

Dosage Duration Effect N
None -- Positive 55
None -- Neutral --
None -- Mixed --
None -- Positive 1
1.57 and 3.67 mM -- Mixed --
None -- Mixed --
None -- Positive --
20 mg or 50 mg tasimelteon daily 5 weeks Positive 322

Best taken: 30-60 minutes before bed

Safety & Side Effects

Reported Side Effects

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams or nightmares

Known Interactions

  • Blood thinners (warfarin) — may increase bleeding risk
  • Immunosuppressants — melatonin may stimulate immune function
  • Diabetes medications — may affect blood sugar levels
  • Sedatives and CNS depressants — additive drowsiness

Tolerable upper intake: No established UL; 5 mg typically considered maximum

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Melatonin help with Circadian Rhythm Disorder?
Based on 176 studies with 4,513 participants, there is strong evidence from multiple clinical trials that Melatonin may support Circadian Rhythm Disorder management. Our evidence grade is A (Strong Evidence).
How much Melatonin should I take for Circadian Rhythm Disorder?
Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Melatonin?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Melatonin and Circadian Rhythm Disorder?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 176 peer-reviewed studies with 4,513 total participants. The overall direction of effect is mixed.

Related Evidence

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.